Generate a tailored SOP for Dr. Christine Bestvina. Improve your application with a focused, well-structured draft.
Christine M. Bestvina is an Associate Professor of Medicine and serves as the Associate Director of Clinical Operations for Thoracic Oncology at the University of Chicago. She specializes in the treatment of Non-Small Cell Lung Cancer and Small Cell Lung Cancer, focusing on advanced clinical practices such as immunotherapy and targeted therapy combined with ablative radiotherapy. Dr. Bestvina leads several investigator-initiated cooperative-group clinical trials, notably as the National Principal Investigator for the A082002 trial that evaluates the efficacy of immunotherapy in conjunction with radiation for advanced PD-L1–negative NSCLC. Her contributions to thoracic oncology extend to notable involvement in various professional organizations like the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO), where she actively participates in leadership roles and offers extensive expertise. Dr. Bestvina has been widely acknowledged, including being listed in Chicago Magazine’s Top Doctors from 2023 to the present, reflecting her dedication to both clinical practice and education. A committed educator and mentor, she has received multiple teaching awards recognizing her efforts in advancing research that aims to improve patient outcomes in thoracic malignancies.
Department of Philosophy